• +1-646-491-9876
    • +91-20-67278686

    Search

    Hyperalgesia-Pipeline Review H2 2017

    Hyperalgesia-Pipeline Review H2 2017

    • Report Code ID: RW0001881448
    • Category Life Sciences
    • No. of Pages 31
    • Publication Month Jul-17
    • Publisher Name Global Markets Direct
    Hyperalgesia-Pipeline Review H2 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Hyperalgesia-Pipeline Review H2 2017 provides an overview of the Hyperalgesia (Central Nervous System) pipeline landscape.

    Hyperalgesia is an increase in pain response. Predisposing factors include long term opioid usage inflammation damage to nociceptors damage to peripheral nerves and psychological disorders. Treatment includes antidepressants and Non-steroidal anti-inflammatory drugs.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Hyperalgesia-Pipeline Review H2 2017 provides comprehensive information on the therapeutics under development for Hyperalgesia (Central Nervous System) complete with analysis by stage of development drug target mechanism of action (MoA) route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics its complete research and development history and latest news and press releases.

    The Hyperalgesia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Hyperalgesia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes the molecules developed by Companies in Preclinical stages are 5 respectively. Similarly the Universities portfolio in Preclinical stages comprises 4 molecules respectively.

    Hyperalgesia (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases company/university websites clinical trial registries conferences SEC filings investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Hyperalgesia (Central Nervous System) .
    - The pipeline guide reviews pipeline therapeutics for Hyperalgesia (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise product description descriptive licensing and collaboration details R&D brief MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Hyperalgesia (Central Nervous System) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Hyperalgesia (Central Nervous System) therapeutics based on mechanism of action (MoA) drug target route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Hyperalgesia (Central Nervous System)

    Reasons to buy

    - Procure strategically important competitor information analysis and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Hyperalgesia (Central Nervous System) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Hyperalgesia (Central Nervous System) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    Hyperalgesia-Overview
    Hyperalgesia-Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Pipeline by Universities/Institutes
    Products under Development by Companies
    Products under Development by Universities/Institutes
    Hyperalgesia-Therapeutics Assessment
    Assessment by Target
    Assessment by Mechanism of Action
    Assessment by Route of Administration
    Assessment by Molecule Type
    Hyperalgesia-Companies Involved in Therapeutics Development
    Cara Therapeutics Inc
    Novartis AG
    Hyperalgesia-Drug Profiles
    AX-007-Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    BAM-822-Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    BI-113823-Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    CR-701-Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    GERP-001-Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    ICE-3682-Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    ketoprofen-Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    LASSBio-873-Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecules to Antagonize GPR4 for Arthritis Hyperalgesia and Oncology-Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Hyperalgesia-Dormant Projects
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for Hyperalgesia H2 2017
    Number of Products under Development by Companies H2 2017
    Number of Products under Development by Universities/Institutes H2 2017
    Products under Development by Companies H2 2017
    Products under Development by Universities/Institutes H2 2017
    Number of Products by Stage and Target H2 2017
    Number of Products by Stage and Mechanism of Action H2 2017
    Number of Products by Stage and Route of Administration H2 2017
    Number of Products by Stage and Molecule Type H2 2017
    Hyperalgesia-Pipeline by Boehringer Ingelheim GmbH H2 2017
    Hyperalgesia-Pipeline by Cara Therapeutics Inc H2 2017
    Hyperalgesia-Pipeline by Novartis AG H2 2017
    Hyperalgesia-Dormant Projects H2 2017

    List of Figures

    Number of Products by Top 10 Targets H2 2017
    Number of Products by Stage and Top 10 Targets H2 2017
    Number of Products by Top 10 Mechanism of Actions H2 2017
    Number of Products by Stage and Top 10 Mechanism of Actions H2 2017
    Number of Products by Routes of Administration H2 2017
    Number of Products by Stage and Routes of Administration H2 2017
    Number of Products by Molecule Types H2 2017
    Cara Therapeutics Inc
    Novartis AG

    Request for Sample

    Report Url https://www.reportsweb.com//hyperalgesia-pipeline-review-h2-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url https://www.reportsweb.com//hyperalgesia-pipeline-review-h2-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url https://www.reportsweb.com//hyperalgesia-pipeline-review-h2-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments